SCHEMBL26441808

SCHEMBL26441808

Cc1c(O)cc(C(=O)c2ccc(O)c(O)c2F)cc1O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 1/20 0.54
▸ HSD17B14 Q9BPX1 1/20 0.41
▸ ALDH1A1 P00352 4/20 0.38
▸ MEN1 O00255 4/20 0.38
▸ KMT2A Q03164 4/20 0.38
▸ KDM4E B2RXH2 3/20 0.38
▸ MAPT P10636 3/20 0.38
▸ HPGD P15428 3/20 0.38
▸ RECQL P46063 3/20 0.38
▸ HSD17B10 Q99714 3/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ GMNN O75496 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ TTR P02766 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ THRB P10828 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ NFKB1 P19838 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18993006 0.88 HDAC1 (0.70) HDAC1HSD17B14ALDH1A1MEN1KMT2A
SCHEMBL19763340 0.84 HDAC1 (0.76) HDAC1HSD17B14ALDH1A1MEN1KMT2A
SCHEMBL17357499 0.84 HDAC1 (0.59) HDAC1ALDH1A1MEN1KMT2AKDM4E
SCHEMBL19003428 0.77 HDAC1 (0.76) HDAC1HSD17B14ALDH1A1MEN1KMT2A
SCHEMBL26441880 0.76 HDAC1 (0.58) HDAC1ALDH1A1MEN1KMT2AKDM4E
SCHEMBL26441706 0.74 HDAC1 (0.70) HDAC1ALDH1A1MEN1KMT2AKDM4E
SCHEMBL19003424 0.74 HDAC1 (0.70) HDAC1HSD17B14ALDH1A1MEN1KMT2A
SCHEMBL18241788 0.73 HDAC1 (0.54) HDAC1HSD17B14ALDH1A1MEN1KMT2A
SCHEMBL19003430 0.72 HDAC1 (0.79) HDAC1HSD17B14ALDH1A1MEN1KMT2A
SCHEMBL19003405 0.72 HDAC1 (0.53) HDAC1ALDH1A1MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11639325-B2 Compositions of polyhydroxylated benzophenones and methods of treatment of neurodegenerative disorders MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2023-05-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11639325-B2 Compositions of polyhydroxylated benzophenones and methods of treatment of neurodegenerative disorders HDAC1, HDAC10, HDAC6 HDAC1 1/4885HSD17B14 354/4885ALDH1A1 1510/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback